A comparative study of L-type voltage sensitive Ca2+ channels in rat brain regions and cultured neuronal cells

Neuroscience Letters

Volumn 223, Issue 3, 1997, Pages 169-172

  Hirota, Kazuyoshi ^a   Lambert, David G ^a  

^a LEICESTER ROYAL INFIRMARY   (United Kingdom)

Author keywords

1321N1 cells; dihydropyridines; intracellular calcium; L type voltage sensitive Ca2+ channels; NG108 15 cells; PC12 cells; rat brain; SH SY5Y cells

Indexed keywords

1,4 DIHYDRO 2,6 DIMETHYL 5 NITRO 4 [2 (TRIFLUOROMETHYL)PHENYL] 3 PYRIDINECARBOXYLIC ACID METHYL ESTER; CALCIUM CHANNEL; CALCIUM CHANNEL BLOCKING AGENT; ISRADIPINE; NIFEDIPINE; RADIOLIGAND;

ANIMAL CELL; ANIMAL TISSUE; ARTICLE; BRAIN REGION; CALCIUM TRANSPORT; CELL CULTURE; CONTROLLED STUDY; FEMALE; INTRACELLULAR RECORDING; NONHUMAN; PHEOCHROMOCYTOMA; PRIORITY JOURNAL; RAT; RECEPTOR BINDING;

ANIMALS; BRAIN; CALCIUM; CALCIUM CHANNEL BLOCKERS; CALCIUM CHANNELS; ELECTROPHYSIOLOGY; FEMALE; INTRACELLULAR MEMBRANES; ISRADIPINE; NEURONS; NIFEDIPINE; OSMOLAR CONCENTRATION; PC12 CELLS; POTASSIUM; RATS; RATS, WISTAR; TUMOR CELLS, CULTURED;

EID: 0031038617     PISSN: 03043940     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0304-3940(97)13434-6     Document Type: Article

References (22)

1. 2+ and cyclic AMP. Br. J. Pharmacol. 111:1994;787-792.
2. Caulfield M.P., Robbins J., Brown D.A. Neurotransmitters inhibit the omega-conotoxin-sensitive component of Ca current in neuroblastoma x glioma hybrid (NG 108 15) cells, not the nifedipine-sensitive component. Pflügers Arch. 420:1992;486-492.
3. 50) of an enzymatic reaction. Biochem. Pharmacol. 22:1973;3099-3108.
4. 2+ indicators with greatly improved fluorescence properties. J. Biol. Chem. 260:1985;3440-3449.
5. 3H]PN200-110 to rat brain, SH-SY5Y and NG108-15 membranes. Br. J. Pharmacol. 117:1996;292P.
6. Kasai H., Neher E. Dihydropyridine-sensitive and ω-conotoxin-sensitive calcium channels in a mammalian neuroblastoma-glioma cell line. J. Physiol. 448:1992;161-188.
7. 2+ signaling and transmitter release in a neural cell-line. Anesthesiology. 74:1991;309-319.
8. 2+ entry induced by depolarization and muscarinic receptor stimulation in SH-SY5Y human neuroblastoma cells. Mol. Brain Res. 8:1990;263-266.
9. 2+ channels in mammalian central nervous system. Trends Neurosci. 15:1992;351-355.
10. ++ channels. Glia. 4:1991;448-455.
11. 2+ channels. Br. J. Pharmacol. 113:1994;621-627.
12. Morton A.J., Hammond C., Mason W., Henderson G. Characterisation of the L- and N-type calcium channels in differentiated SH-SY5Y neuroblastoma cells: calcium imaging and single channel recording. Mol. Brain Res. 13:1992;53-61.
13. Owen P.J., Marriott D.B., Boarder M.R. Evidence for a dihydropyridine-sensitive and conotoxin-insensitive release of noradrenaline and uptake of calcium in adrenal chromaffin cells. Br. J. Pharmacol. 97:1989;133-138.
14. Pocock J.M., Cousin M.A. Energetics of cultured neurones and ischaemia. Biochem. Soc. Trans. 22:1994;970-973.
15. Ramkumar V., El-Fakahany E.E. Prolonged morphine treatment increases rat brain dihydropyridine binding sites: possible involvement in development of morphine dependence. Eur. J. Pharmacol. 146:1988;73-83.
16. Reeve H.L., Vaughan P.F.T., Peers C. Calcium channel currents in undifferentiated human neuroblastoma (SH-SY5Y) cells: actions and possible interactions of dihydropyridines and ω-conotoxin. Eur. J. Neurosci. 6:1994;943-952.
17. Seward E.P., Henderson G. Characterization of two components of the N-like, high-threshold-activated calcium channel current in differentiated SH-SY5Y cells. Pflügers Arch. 417:1990;223-230.
18. Smart D., Wandless A., Lambert D.G. Activation of phospholipase C in SH-SY5Y neuroblastoma cells by potassium-induced calcium entry. Br. J. Pharmacol. 116:1995;1797-1800.
19. Spedding M., Lepagnol J. Pharmacology of sodium and calcium channel modulation in neurones: implications for neuroprotection. Biochem. Soc. Trans. 23:1995;633-636.
20. Vaughan P.F.T., Peers C., Walker J.H. The use of the human neuroblastoma SH-SY5Y to study the effect of second messengers on noradrenaline release. Gen. Pharmacol. 26:1995;1191-1201.
21. Wagner J.A., Snowman A.M., Biswas A., Olivera B.M., Snyder S.H. ω-Conotoxin GVIA binding to a high-affinity receptor in brain: characterization, calcium sensitivity, and solubilization. J. Neurosci. 8:1988;3354-3359.
22. Werth J.L., Hirong L.D., Thayer S.A. ω-Conotoxin exerts functionally distinct low and high affinity effects in the neuronal cell line NG108-15. Mol. Pharmacol. 40:1991;742-749.